ISDS Case Map
intellectual property
People afflicted with the Aids virus have called on the government to proceed carefully on free-trade negotiations with the European Union, as the latter's demands for copyright protection could make it difficult for patients to access cheap medicines.
Some countries whose governments purchase drugs with a set budget are also alarmed by signs that the TPP may grant new negotiating powers to the industry.
The letter warns that the TRIPS-Plus provisions in the trade agreement between EU and Thailand – including border measures, data exclusivity, patent term extensions, and protection for new indications – would block access to generic medicines.
Just Foreign Policy is offering a reward, now up to $21,100, to WikiLeaks if it publishes a draft copy of the TPP. People could add to the reward fund, or if in a position to do so, make a copy of the draft agreement available to the world.
Last week, a few short paragraphs of text were leaked that revealed something of the terms on fair use being negotiated in secret by the Trans-Pacific Partnership.
As the nineteenth International AIDS Conference continued in Washington Tuesday, thousands of protesters marched on the White House calling for an end to free trade deals that protesters argue make vital AIDS medicines unaffordable.
Delayed market entry of generics due to enhanced intellectual property protection cost Jordanian private consumers approximately 18 million US dollars annually
In October 2007, several leading economies, including the U.S., European Union, and Canada, announced plans to negotiate the Anti-Counterfeiting Trade Agreement (ACTA).
The EU Parliament has rejected the controversial global Anti-Counterfeiting Trade Agreement. The decision is a victory for thousands of Europeans who took to the streets in furious protest against ACTA.
